BioXcel Therapeutics (BTAI) Stock Chart & Stock Price History $5.04 +0.12 (+2.44%) Closing price 04:00 PM EasternExtended Trading$5.00 -0.04 (-0.79%) As of 07:21 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BioXcel Therapeutics Stock Price Performance The BioXcel Therapeutics (BTAI) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 52.88%, with a year-to-date return of -15.75%. In the past month, the stock has increased 163.87%, reflecting recent market activity. As of the latest close, BioXcel Therapeutics traded at $4.92 with a market cap of $29.82 million and volume of 7.00 million shares. Five years ago, the stock traded at a split-adjusted price of $658.88, representing a 99.24% decrease over that period. At the time, it had a market cap of $940.92 million and a volume of 21,258 shares. Receive BTAI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-8.03%1 Month Performance+163.87%3 Month Performance+254.93%Year-To-Date Performance-15.75%1 Year Performance-52.88%5 Year Performance-99.24% BTAI Stock Chart for Wednesday, August, 20, 2025 BTAI Chart by TradingView BioXcel Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/19/2025$5.67$4.92-13.23%$5.34$4.777.00 million shs$29.82 million08/18/2025$5.48$5.67+3.47%$6.85$5.4634.56 million shs$34.36 million08/15/2025$4.75$5.48+15.37%$5.49$4.108.78 million shs$33.21 million08/14/2025$5.60$4.75-15.18%$6.23$4.618.24 million shs$28.79 million08/13/2025$6.80$5.60-17.65%$7.36$5.1615.39 million shs$33.91 million08/12/2025$6.40$6.80+6.25%$8.08$4.8035.40 million shs$41.21 million08/11/2025$4.04$6.40+58.42%$6.69$4.2741.33 million shs$38.78 million08/08/2025$3.41$4.04+18.48%$4.68$3.5743.03 million shs$24.48 million08/07/2025$3.32$3.41+2.71%$3.70$3.0614.60 million shs$20.65 million08/06/2025$2.97$3.32+11.78%$3.84$2.9848.74 million shs$20.12 million Get the Latest News and Ratings for BTAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/05/2025$2.54$2.97+16.93%$3.48$2.2639.77 million shs$18.00 million08/04/2025$1.37$2.54+85.40%$2.75$1.5881.09 million shs$15.38 million08/01/2025$1.31$1.37+4.58%$2.07$1.33109.14 million shs$8.30 million07/31/2025$1.43$1.31-8.39%$1.51$1.30429,478 shs$7.94 million07/30/2025$1.59$1.43-10.06%$1.59$1.39387,700 shs$8.67 million07/29/2025$1.70$1.59-6.47%$1.76$1.57282,250 shs$9.63 million07/28/2025$1.81$1.70-6.08%$1.82$1.65351,003 shs$10.30 million07/25/2025$1.73$1.81+4.62%$1.83$1.75213,740 shs$10.97 million07/24/2025$1.81$1.73-4.42%$1.80$1.70334,500 shs$10.48 million07/23/2025$1.81$1.81+0.28%$1.87$1.75372,050 shs$10.97 million07/22/2025$1.89$1.81-4.50%$1.92$1.74384,233 shs$10.94 million07/21/2025$1.91$1.89-1.05%$1.95$1.88263,511 shs$11.45 million Related Companies Citius Oncology Stock Price Chart Climb Bio Stock Price Chart ALT5 Sigma Stock Price Chart Alpha Cognition Stock Price Chart Inhibikase Therapeutics Stock Price Chart Compugen Stock Price Chart Scilex Stock Price Chart Fate Therapeutics Stock Price Chart Protalix BioTherapeutics Stock Price Chart Coherus Oncology Stock Price Chart Receive BTAI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BTAI) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioXcel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioXcel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access